Home / Inspections / 964577

FDA Inspection 964577 — Morton Grove Pharmaceuticals, Inc.

Morton Grove Pharmaceuticals, Inc. — FEI 1420913

The FDA completed an inspection of Morton Grove Pharmaceuticals, Inc. on February 5, 2016 in Morton Grove, IL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 5, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Morton Grove, IL (United States)

Facility

Other inspections at this facility

  • 870006 (VAI Wed Mar 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 702633 (VAI Tue Apr 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 651880 (VAI Wed Mar 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 614298 (NAI Thu Sep 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 568902 (VAI Tue Mar 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources